Showing 35,658 results

Resistance

CROI: Further evidence that short-course PMTCT prophylaxis compromises mother's future treatment

News
1 March 2007
Starting treatment

CROI: Ugandan study confirms low CD4 count, low body weight, TB and anaemia major risk factors for death after starting ART

News
1 March 2007
Side effects

CROI: Kaletra less likely to cause fat loss than efavirenz when paired with NRTIs

News
28 February 2007
Improving HIV care

CROI: Non-AIDS malignancies now more common than AIDS-defining cancers in people with HIV

News
28 February 2007
People with limited treatment options

CROI: Maraviroc shows potent effect in highly treatment-experienced

News
28 February 2007
Opportunistic infections

CROI: Cotrimoxazole prophylaxis reduces risk of death by 41% during first six months of ART

News
28 February 2007
HIV & criminal law

Scientific evidence alone cannot prove liability in criminal HIV transmission cases

News
28 February 2007
Transmission & prevention

CROI: Microbicide failure poses more questions than answers

News
28 February 2007
People with limited treatment options

CROI: Integrase inhibitor raltegravir (MK-0518) doubles HIV suppression in treatment-experienced patients at 16 weeks

News
28 February 2007
Low CD4 count

CROI: HIV treatment should not be delayed in TB patients with low CD4 counts, South African study shows

News
28 February 2007
How HIV works

CROI: Women infected with HIV subtype D progress faster despite same viral load

News
27 February 2007
HIV treatment

CROI: MSF reports good responses on PI-based second-line ART regimens even though switch from failing regimens comes late

News
27 February 2007
Transmission & prevention

CROI: Tenofovir microbicide stops rectal infection in monkeys better than PrEP

News
27 February 2007
Starting treatment

CROI: Lower CD4 count on HIV treatment predicts higher risk of cancers, liver, kidney, cardiovascular disease

News
27 February 2007
Side effects

CROI: Growth hormone stimulant TH9507 safe and effective in HIV lipodystrophy

News
27 February 2007
Starting treatment

CROI: Efavirenz-based ART more effective than nevirapine-based ART as first-line therapy in Southern Africa

News
27 February 2007
Bone & joint problems

CROI: Alendronate effectively treats bone loss in men and women with HIV

News
27 February 2007
Treatment interruptions

CROI: SMART analysis reveals slightly elevated risk of cardiovascular disease in people who interrupt therapy

News
27 February 2007
Drug-resistant TB

CROI: Urgent action needed to avert `catastrophic` drug-resistant TB epidemic

News
26 February 2007
Resistance

Health Canada issues warning on use of Baraclude alone in HIV/hepatitis B coinfected

News
22 February 2007
Drug-resistant TB

Poor infection control, not poor adherence, responsible for vast majority of drug-resistant TB in Chinese study

News
22 February 2007
Transmission & prevention

Anti-herpes treatment reduces HIV levels; treatment or vaccine urged for HIV prevention

News
21 February 2007
New & experimental HIV treatments

Merck announces plans for licensing Atripla widely in developing world

News
20 February 2007

HIV Weekly - February 20th 2007

February 2007